Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Karl G. Braslis, Richard C. David, Eustos Nelson, Francisco Civantos, Mark S. Soloway

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

Original languageEnglish
Pages (from-to)329-331
Number of pages3
JournalUrology
Volume45
Issue number2
DOIs
StatePublished - Jan 1 1995

Fingerprint

Flutamide
Gonadotropin-Releasing Hormone
Prostate
Squamous Cell Carcinoma
Adenocarcinoma
Leuprolide
Luteinizing Hormone
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Squamous cell carcinoma of the prostate : a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide. / Braslis, Karl G.; David, Richard C.; Nelson, Eustos; Civantos, Francisco; Soloway, Mark S.

In: Urology, Vol. 45, No. 2, 01.01.1995, p. 329-331.

Research output: Contribution to journalArticle

@article{89319100c9424e129d11e6146211bbd7,
title = "Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide",
abstract = "We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.",
author = "Braslis, {Karl G.} and David, {Richard C.} and Eustos Nelson and Francisco Civantos and Soloway, {Mark S.}",
year = "1995",
month = "1",
day = "1",
doi = "10.1016/0090-4295(95)80028-X",
language = "English",
volume = "45",
pages = "329--331",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Squamous cell carcinoma of the prostate

T2 - a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

AU - Braslis, Karl G.

AU - David, Richard C.

AU - Nelson, Eustos

AU - Civantos, Francisco

AU - Soloway, Mark S.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

AB - We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

UR - http://www.scopus.com/inward/record.url?scp=0029245715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029245715&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(95)80028-X

DO - 10.1016/0090-4295(95)80028-X

M3 - Article

C2 - 7855985

AN - SCOPUS:0029245715

VL - 45

SP - 329

EP - 331

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -